Economic report on antibiotics manufacture.

  • United States. Federal Trade Commission.
Date:
1958
Catalogue details

Licence: Public Domain Mark

Credit: Economic report on antibiotics manufacture. Source: Wellcome Collection.

    10/380
    CHAPTER VII Analysis of Financial Data Submitted by Antibiotics Manufacturers Page Size.of maniutacturing companies: 22.2 02. lea cee oe ee 199 Company sales Of antioierics. 2. =... be ce ee 200 Accounting practices and probleme. =o 2-0 ee 202 Ingome-and: expenses: os oe Se Se Sl as eee ee ee 203 Methodcor analysiss A> 252. os eee ee ee ee 203 judinidualtproducers..2.8 2. > 2S gen Pee ie ee 204 Industry -ratioss. 2 25s eee. eee ee ee ke ne 209 AMtIOIOUICS CROWD TaAtlOda ek. ee 210 Profit: COMMDATISONS= 5 ft ee eS yo he a er ee, 214 Profits compared to assets of selected antibiotics manufacturers _ _ ___ 214 Comparison of antibiotics profits with pharmaceutical and consol- WCAC EC MeL OMUS es 2s Fras 2 ee ne ie eee ke 215 Graphic analysis of antibiotics and pharmaceutical profits__________ 221 Comparison with profits in all manufacturing industries and in chemicaliindustry eS. aso. 6 oe eas ee eee ee 223 CHAPTER VIII Patent Ownership and Licensing in the Antibiotics Industry AtrOGUCUON 2 ice ouc oe ek cite ee ee ee Oe ee 225 Product patents im the antibiotics Industry 2.222.525.2225. .2 2 - ee 227 The importance of patents covering antibiotic products____________- 228 B60 (ar | ae eae ee ee EN RE SAE IO A dace Ben ee ke eee ome 228 Sine PbOMUy CIN. ko oo saa eee = city ee ee ne ee 229 The four broad spectrum antibioties 2.45 Sa ee 231 PUPy URTORVY CIN as oe OS ce Se oes ES eee ee ee et 233 Patent ownership in the antibiotics industry_________________-_______- 234 Patent licensing in the antibioties industry_-_..........._.....-..___-_ 237 Sicniicant patent WMtisavion. . 2-2 eee ee ee eee 242 Procaiie pemieulinn.. <one aso eed ow ee Se Sree eee i ee 242 etree welinen. soe SUE Se Ne Se eS ee ee 245 ‘Ehe@roriginvoty tetracycline <2... See oe ee oe eee. 248 The first tetracycline interference (No. 86,799).___.__________. 248 The tetracycline ‘‘salt” interference (No. 86,861)_____________- 250 Cyanamid’s license to Bristol to make tetracycline____._______- 252 Issuance of the tetracycline product patent to Pfizer__________ 252 The tetracycline patent litigation._.............22.2...2.. ae Nee 253 The tetracycline settlement agreements___.__._.______.______-. 254 The Pfizer-Bristol agreement_.....................-....- 255 The Pfizer-Olin Mathieson agreement; the Pfizer-Upjohn SereemMente Sree ek Se Se ee ee 256